SCOPUS 정보 검색 플랫폼

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 1, 2009, Pages 42-45

Diclofenac sodium 3% gel as a potential treatment for disseminated superficial actinic porokeratosis

(7) Marks, S a Varma, R a Cantrell, W a Chen, Sc d Gold, M c Muellenhoff, M b Elewski, B a

a UNIVERSITY OF ALABAMA AT BIRMINGHAM (United States)

b Sierra Dermatology (United States)

c GOLD SKIN CARE CENTER (United States)

d EMORY UNIVERSITY (United States)

Author keywords

Actinic; Diclofenac; DSAP; Porokeratosis

Indexed keywords

DICLOFENAC;

ACTINIC POROKERATOSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED STUDY; DERMATITIS; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; ERYTHEMA; HUMAN; HUMAN TISSUE; MULTICENTER STUDY; PATIENT SATISFACTION; PRIORITY JOURNAL; QUESTIONNAIRE; SKIN BIOPSY; TREATMENT RESPONSE;

ADULT; DICLOFENAC; GELS; HUMANS; KERATOSIS, ACTINIC; PILOT PROJECTS; POROKERATOSIS; QUESTIONNAIRES;

EID: 57649192845 PISSN: 09269959 EISSN: 14683083 Source Type: Journal
DOI: 10.1111/j.1468-3083.2008.02943.x Document Type: Article

Times cited : (26)

References (6)

1
- 57649145835
- Accessed March 1, Available at
- Spencer LV. Porokeratosis. eMedicine website. Accessed March 1, 2007. Available at http://www.emedicine.com/derm/topic343.htm.
- (2007) Porokeratosis. EMedicine Website
- Spencer, L.V.¹

2
- 21644479984
- Common skin cancers in porokeratosis
- Maubec E, Duvillard P, Margulis A, Bachollet B, Degois G, Avril M-F. Common skin cancers in porokeratosis. Br J Dermatol 2005 152 : 1360 1398.
- (2005) Br J Dermatol , vol.152 , pp. 1360-1398
- Maubec, E.¹ Duvillard, P.² Margulis, A.³ Bachollet, B.⁴ Degois, G.⁵ Avril, M.-F.⁶

3
- 0024372404
- Disseminated superficial actinic porokeratosis: A clinical study
- Shumack SP, Commens CA. Disseminated superficial actinic porokeratosis: a clinical study. J Am Acad Derm 1989 20 : 1015 1022.
- (1989) J Am Acad Derm , vol.20 , pp. 1015-1022
- Shumack, S.P.¹ Commens, C.A.²

4
- 0035659622
- Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses
- Wolf JE, Taylor JR, Tschen E, Kang S. Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int J Derm 2001 40 : 709 713.
- (2001) Int J Derm , vol.40 , pp. 709-713
- Wolf, J.E.¹ Taylor, J.R.² Tschen, E.³ Kang, S.⁴

5
- 57649145939
- Solaraze® Gel (diclofenac sodium-3%) [package insert]. Bradley Pharmaceuticals, Inc website. Accessed March 1, Available at
- Solaraze® Gel (diclofenac sodium-3%) [package insert]. Bradley Pharmaceuticals, Inc website. Accessed March 1, 2007, Available at http://www.bradpharm.com/products/Doak/prescription/pdf/Solaraze_Gel_PI_IL206. pdf.
- (2007)

6
- 34249829606
- Genital porokeratosis: Treatment with diclofenac topical gel
- Kluger N, Dereure O, Guilhou JJ, Guillot B. Genital porokeratosis: treatment with diclofenac topical gel. J Dermatolog Treat 2007 18 : 188 190.
- (2007) J Dermatolog Treat , vol.18 , pp. 188-190
- Kluger, N.¹ Dereure, O.² Guilhou, J.J.³ Guillot, B.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.